<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>School of Public Health</title>
<link>http://ir.mu.ac.ke:8080/jspui/handle/123456789/47</link>
<description/>
<pubDate>Sun, 28 Jun 2026 07:12:58 GMT</pubDate>
<dc:date>2026-06-28T07:12:58Z</dc:date>
<item>
<title>Prevalence and factors associated with modern contraceptive use among female adolescents aged 15-19 years in Kenya</title>
<link>http://ir.mu.ac.ke:8080/jspui/handle/123456789/10218</link>
<description>Prevalence and factors associated with modern contraceptive use among female adolescents aged 15-19 years in Kenya
Salat, Ednah Chepngeno
Adolescent sexual and reproductive health (ASRH) contributes to the global burden of &#13;
sexual ill health, with unmet needs persisting worldwide. Kenya's government &#13;
reaffirms its commitment to increasing the contraceptive prevalence among adolescents &#13;
aged 15-19 to 55% by 2025 from the current 10%. Only 43.8% of married and 36.9% &#13;
of sexually active unmarried adolescents (15-19) used any method of contraception as &#13;
of 2022 in Kenya. The objectives were; to determine the demographic and social &#13;
characteristics (Age, education, marital status, parity, economic status), and prevalence &#13;
of modern contraceptive use among female adolescents and to identify associated &#13;
factors. The study utilized secondary data from Kenya's 2021 Performance Monitoring &#13;
for Action (PMA) survey. The data extraction process focused on identifying and &#13;
filtering female adolescents aged 15-19 who met specific inclusion criteria: sexually &#13;
active, married or unmarried, and present during the survey period. After applying these &#13;
criteria, the final weighted sample consisted of 344 respondents. Descriptive analyses &#13;
were conducted to calculate the mean values and proportions for the relevant variables. &#13;
Bivariate analysis was carried out to determine the association between outcome &#13;
(modern contraceptive use) and exposure variables. All variables with a p-value&gt;0.2 at &#13;
the bivariate level were subjected to a multivariable binary logistic regression model. &#13;
Stepwise backward elimination unconditional logistic regression was used to develop &#13;
the final model. All variables with p-values &gt;0.05 at a multivariable level were regarded &#13;
as independently associated with modern contraceptives. According to the results of &#13;
the 344 sexually active girls, 169 were using modern contraceptives, giving a &#13;
prevalence of 49.1% (95% CI: 43.8- 54.4). The mean age was 17.8 years (SD+/-1.7), &#13;
with the age group 18-19 years contributing 64.8% of the respondents, with a &#13;
prevalence of 57.4%. Those who reported being married or staying with a partner as if &#13;
married had 46.3% using modern contraceptives, while those with secondary and &#13;
higher education had 51.9% using modern contraceptives. The odds of modern &#13;
contraceptive use were 2.0 times higher among those adolescents aged 18-19 years &#13;
(AOR 2.0, 95% CI, 1.21-3.45, p&lt;0.005) compared to adolescents aged 15- 17 years. &#13;
Those who reported having one child had 2.2 odds of using modern contraceptives &#13;
compared to those who had never had a child before (AOR 2.2, 95% CI, 1.17-4.24, &#13;
p&lt;0.05). Other factors that were independently associated with modern contraceptive &#13;
use include household wealth quantiles (AOR 4.9 CI 95%, 2.08-11.29, p&lt;0.05) and the &#13;
perception that the community’s view a few adolescents using modern contraceptives &#13;
were promiscuous (AOR 0.4. 95% CI, 0.2-0.78, p&lt;0.05). In conclusion Age, education, &#13;
and economic resources have a positive impact on modern contraceptive use, while &#13;
community perceptions have a negative influence. These factors are key in shaping the &#13;
contraceptive behavior of adolescents in Kenya.  Recommending this a targeted &#13;
comprehensive approach encompassing education on sexual reproductive health, &#13;
awareness-raising, and community engagement is paramount in empowering &#13;
adolescents to make informed decisions about their reproductive health
</description>
<pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://ir.mu.ac.ke:8080/jspui/handle/123456789/10218</guid>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Factors associated with mortality among severely ill covid-19 patients, Nairobi metropolis, Kenya</title>
<link>http://ir.mu.ac.ke:8080/jspui/handle/123456789/10211</link>
<description>Factors associated with mortality among severely ill covid-19 patients, Nairobi metropolis, Kenya
Muendo, Charles Mulwa
Background: Severe Coronavirus Disease 2019 (COVID-19) occurs in about 20% of&#13;
hospitalized patients. Many of these patients have comorbidities and are the main&#13;
contributors for COVID-19 mortality. The most common underlying conditions include&#13;
hypertension, diabetes, and chronic lung disease.&#13;
Objectives: To describe socio-demographic factors of severe COVID-19 patients;&#13;
determine the clinical, laboratory, and radiological characteristics and outcomes of&#13;
severe COVID-19 disease; and evaluate the predictors of mortality for severely ill&#13;
COVID-19 patients.&#13;
Methods: A cross-sectional study in Nairobi Metropolis was conducted between&#13;
September and December 2021. Patient information was collected from the inpatient&#13;
registers of selected hospitals with COVID-19 isolation centers. This included&#13;
demographic and clinical information, presenting signs and symptoms, laboratory and&#13;
radiological findings during hospitalization, and case management. A severe COVID-&#13;
19 patient was defined as any COVID-19 patient with any of the following: oxygen&#13;
saturation &lt;94% in room air, respiratory rate &gt;30 breaths/minute, and any signs of&#13;
respiratory distress such as difficulty in breathing, or rapid breathing, confusion,&#13;
reduced blood pressure, low blood oxygen, and tiredness. Mortality (case) was defined&#13;
as any patient with severe COVID-19 infection who died, as recorded and reported by&#13;
the hospital. Non-case was defined as any patient who survived a severe COVID-19&#13;
infection. Means and medians were calculated for continuous variables, and&#13;
frequencies and proportions for categorical variables. Chi-square and multivariable&#13;
binary logistic regression compared exposure factors with disease outcome. The study&#13;
proposal was approved by Moi University Institutional Research Ethics Committee&#13;
(IREC).&#13;
Results: Total abstracted records were for 818 patients; 500 (61%) severe patients (153&#13;
non-survivors, 347 survivors). The analysis involved 150 non-survivors and 150&#13;
survivors. Males were 66.8%, and a mean age of 53.29 years ± 17.7. Sixty-four (64.3)&#13;
percent presented with difficulty breathing, cough 63.7%, while 33.3% had a fever.&#13;
Patients with Peripheral Oxygen Saturation (SPO2) of ≤94% were 39.9% at admission,&#13;
rising to 90.0% during isolation. Patients with underlying diabetes were 29.3%, while&#13;
hypertension/heart disease was 28.3%. Patients that developed acute respiratory&#13;
distress syndrome (ARDS) were 26.0%. Patients put on oxygen therapy were 28.3%,&#13;
mechanical ventilation 19.3%, and ICU admissions were 3.7%. Factors significantly&#13;
associated with death were: hypertension (OR-3.5, 95% CI- 1.34–9.45, p-value- 0.011);&#13;
ARDS (OR- 8.9, 95% CI- 3.05–26.14, p-value- &lt;0.001); severe disease at admission&#13;
(OR- 18.7, 95% CI- 5.24–67.15, p-value &lt;0.001); and failure to receive oxygen&#13;
treatment (OR- 17.5, 95% CI- 5.54–55.32, p-value &lt;0.001).&#13;
Conclusion: The results highlighted that advanced age, hypertension, hypoxia at&#13;
admission, and lack of oxygen therapy were independently associated with increased&#13;
risk of death. These findings are consistent with international evidence, yet they also&#13;
reflect unique health system challenges within the Kenyan context.&#13;
Recommendation: We recommend that the government of Kenya, through the&#13;
Ministry of Health, should: enhance early risk stratification and triage, scale up&#13;
oxygen supply and infrastructure, expand intensive care capacity, and improve&#13;
management of non-communicable diseases, among others.
</description>
<pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://ir.mu.ac.ke:8080/jspui/handle/123456789/10211</guid>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>The factors associated with the uptake of intermittent preventive treatment of Malaria in pregnancy in Nambale Sub-County Hospital, Kenya</title>
<link>http://ir.mu.ac.ke:8080/jspui/handle/123456789/10205</link>
<description>The factors associated with the uptake of intermittent preventive treatment of Malaria in pregnancy in Nambale Sub-County Hospital, Kenya
Angute, Collins Omondi
Background: Malaria remains a significant public health problem globally, with highest &#13;
morbidity and mortality reported in sub Saharan Africa. In 2022, there were 12.7 million &#13;
(36%) cases of Malaria in Pregnancy (MiP) in Sub Saharan Africa and 27% were reported &#13;
from East Africa. In Kenya, there were a total of 4,080,441 malaria cases and 5% MiP &#13;
cases. Busia County in Western Kenya reported 341,886 malaria cases and 22% MiP &#13;
cases. WHO recommends administering intermittent preventive treatment of malaria in &#13;
pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) as preventive   treatment for &#13;
malaria in pregnancy (MIP) in malaria-endemic zones to prevent MiP.  &#13;
Objectives: To determine proportion of pregnant women of nine months’ pregnancy &#13;
utilizing IPTp-SP 3 and to describe sociodemographic, health facility and individual &#13;
factors influencing utilization of IPTp-SP 3 among pregnant women of nine months’ &#13;
pregnancy attending antenatal care at Nambale Sub-County Hospital in Busia County. &#13;
Methods: This was a cross-sectional study that employed consecutive sampling &#13;
whereby, pregnant women of nine months, aged between 14-49 years were interviewed, &#13;
using the interviewer- administered questionnaires on Kobo-collect. The dependent &#13;
variable was the uptake of three doses of IPTp-SP, with sociodemographic, health facility &#13;
and individual factors as the independent variables. A Descriptive of factors was done, &#13;
Chi square test was used in bivariate analysis to determine association between &#13;
independent variables and dependable variables, variable with p value of ≤0.2, were &#13;
subjected to multivariable logistic regression analysis to identify variables with p value &#13;
of ≤0.05 associated with utilization of IPTp-SP among pregnant women.  &#13;
Results: A total of 384 pregnant women were interviewed. Their median age was 25 years &#13;
(range of 14 – 49 years), 68% (262/384) were married and 90% (348/384) of all the participants &#13;
resided in rural areas. More than half of the participants, 60% (232/384) utilized IPTp&#13;
SP3. Awareness of use and the benefits of IPTp was reported by 93% (256/384) of &#13;
participants. Majority of the respondents, 67% (258/384) were unemployed, and 47% &#13;
(182/384) had secondary education as their highest level of education. In the bivariate &#13;
analysis, participant age 21-30 years {cOR=2.34, 95% CI=1.4–3.7}, belief that &gt;3 doses &#13;
of IPTp prevented MiP {cOR=3.09, 95% CI=1.5–6.2}and participant having attained &#13;
tertiary education {cOR=2.71, 95% CI=1.4–5.1} were associated with uptake of three or &#13;
more doses of IPTp by the participants. On multivariable logistics regression analysis, &#13;
attendance of ANC at least 4 times {aOR=8.42, 95% CI=4.4–16.0} and participants &#13;
taking IPTp-SP for the first time at 14-17 gestation weeks {aOR=7.79, 95% CI=3.2&#13;
18.7} were factors independently associated with optimal utilization of IPTp (IPTp-SP3). &#13;
Conclusion: A sub-optimal IPTp-SP 3 utilization (60%) way below WHO target &#13;
recommendation of 80%. More than four ANC attendance with the first IPTp-SP uptake &#13;
beginning 14-17 gestation weeks were independently associated with optimal utilization &#13;
of IPTp (IPTp-SP3). &#13;
Recommendation: Pregnant women attending ANC at the facility should ensure that &#13;
they attend ANC at least four times and take at least three doses of IPTp for maximum &#13;
protection against malaria in pregnancy. Enhanced risk communication and community &#13;
engagement by the community health volunteers on IPTp-SP awareness and importance. &#13;
Key Words: FELTP, IPTp-SP, Kenya, Malaria, Pregnancy, WHO
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://ir.mu.ac.ke:8080/jspui/handle/123456789/10205</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Pesticide applicators’ knowledge, attitudes and practices of pesticide use and exposure in floriculture farms in Naivasha, Kenya</title>
<link>http://ir.mu.ac.ke:8080/jspui/handle/123456789/10190</link>
<description>Pesticide applicators’ knowledge, attitudes and practices of pesticide use and exposure in floriculture farms in Naivasha, Kenya
Muniu, Samuel Kimani
Introduction: Pesticides are widely used in agriculture to boost yields and reduce pest&#13;
related losses. Global pesticide use has doubled since 1990, reaching 3.70 million &#13;
tonnes in 2022, with Africa's usage rising by 185% over the same period. However, &#13;
Africa saw a slight decline from 210,000 tonnes in 2021 to 209,000 tonnes in 2022, &#13;
with most pesticides imported. In Kenya, use peaked at 6,228 tonnes in 2020 before &#13;
falling to 5,083 in 2022. A study in Naivasha found 141 pesticides in 20 horticultural &#13;
farms, 4.3% classified by WHO as highly hazardous (Mburu et al., 2013). These &#13;
statistics highlight that pesticides are still in use, yet their usage poses significant health &#13;
risks to pesticide applicators working in floriculture farms due to occupational &#13;
exposure. Despite continued pesticide reliance and health risks for workers, little &#13;
research explores knowledge, attitudes, and practices (KAP) related to pesticide &#13;
exposure, particularly in Naivasha’s floriculture industry. &#13;
Objective: The study aimed to identify pesticide applicators’ knowledge of safe &#13;
pesticide use and the potential health risks associated with exposure in floriculture &#13;
farms. Secondly, it examined pesticide applicators’ attitudes towards pesticide use, &#13;
safety measures, and their perceived risks in floriculture farms. Thirdly, it evaluated the &#13;
practices of pesticide applicators regarding protective measures, handling, and &#13;
application of pesticides in floriculture farms. &#13;
Methods: A cross-sectional study conducted in May and June 2014 involving 168 &#13;
pesticide applicators from floriculture farms in Naivasha, selected using multistage &#13;
sampling. Data collection involved an interviewer-administered questionnaire. Ethical &#13;
approval was obtained. Informed consent was secured from all participants prior to data &#13;
collection. Data were analyzed using statistical methods: knowledge (0–23) was &#13;
categorized using the Benjamin Bloom’s scale, attitudes (0–39) as positive/negative, &#13;
and risky behaviours (0–26) with scores above 15 indicating higher risk. Descriptive &#13;
statistics summarized findings, while Mann-Whitney and Kruskal-Wallis tests &#13;
examined socio-demographic associations (p &lt; 0.05). The Kolmogorov-Smirnov test &#13;
assessed the normality of KAP scores. &#13;
Results: All study participants were male, with an average age of 29; most (84.5%) &#13;
were married, and half had attained post-primary education. Although 60.1% had high &#13;
knowledge and 75% had positive attitudes toward safe pesticide use, 97.6% participated &#13;
in risky practices. While higher knowledge (2[2] = 14.539, p = 0.001) and positive &#13;
attitudes (U = 3092, p = 0.023) were significantly associated with reduced risky &#13;
practices, they were not sufficient alone to ensure safe practices. Instead, the study &#13;
found that older age (U = 1676, p &lt; 0.001), being married (U = 2731, p &lt; 0.001), higher &#13;
educational levels (U = 2280, p &lt; 0.001), and increased experience with pesticide usage &#13;
(U = 1760.5, p &lt; 0.001) were also significantly linked to safer behaviour. &#13;
Conclusion: Effective pesticide safety requires more than knowledge and positive &#13;
attitudes. Addressing key demographic factors like age, education, and experience is &#13;
crucial to reduce risky practices. &#13;
Recommendations: To improve pesticide safety in floriculture farms, stakeholders &#13;
should provide training, raise awareness, and enforce protective measures. Educating &#13;
pesticide applicators on health risks, promoting responsible attitudes, and ensuring &#13;
proper equipment use will reduce hazardous exposure
</description>
<pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://ir.mu.ac.ke:8080/jspui/handle/123456789/10190</guid>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
